Institutional investors hold a majority ownership of MRK through the 76.06% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended December 2014, these large investors purchased a net $6.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ABERDEEN ASSET INVESTMENTS LTD. Bought 425.9 Thousand shares of Merck
AMUNDI SMITH BREEDEN LLC Bought 187.3 Thousand shares of Merck